renal toxicity

You have access
Kidney Doses in ¹⁷⁷Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible?
Michael Mix, Tobias Renaud, Felix Kind, Ursula Nemer, Elham Yousetzadeh-Nowsha, Tumelo C.G. Moalosi, Aymen M. Ormrane, Philipp T. Meyer and Juri Ruf

Journal of Nuclear Medicine February 1, 2022, 63 (2) 253-258; DOI: https://doi.org/10.2967/jnumed.121.262245
You have access
¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney
Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Christiane Schuchardt, Karin Niepsch, Thomas Langbein and Richard P. Baum

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1579-1586; DOI: https://doi.org/10.2967/jnumed.118.223149

Main menu